Loree, Jonathan M <br/><br/>
CAPOX associated with toxicities of higher grade but improved disease-free survival when compared with FOLFOX in the adjuvant treatment of stage III colon cancer.  [electronic resource] 

 -  Clinical colorectal cancer  Sep 2014 
 - 172-7 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1938-0674 
<br/><br/><label>Standard No.: </label>10.1016/j.clcc.2014.01.001  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Capecitabine<br/>Chemotherapy, Adjuvant<br/>Colonic Neoplasms--drug therapy<br/>Deoxycytidine--administration & dosage<br/>Disease-Free Survival<br/>Female<br/>Fluorouracil--administration & dosage<br/>Humans<br/>Leucovorin--administration & dosage<br/>Male<br/>Middle Aged<br/>Neoplasm Staging<br/>Organoplatinum Compounds--administration & dosage<br/>Oxaliplatin<br/>Retrospective Studies<br/>Survival Rate